SI0825860T1 - Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients - Google Patents

Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients

Info

Publication number
SI0825860T1
SI0825860T1 SI9630321T SI9630321T SI0825860T1 SI 0825860 T1 SI0825860 T1 SI 0825860T1 SI 9630321 T SI9630321 T SI 9630321T SI 9630321 T SI9630321 T SI 9630321T SI 0825860 T1 SI0825860 T1 SI 0825860T1
Authority
SI
Slovenia
Prior art keywords
amoxycillin
medicament
manufacture
treatment
composition
Prior art date
Application number
SI9630321T
Other languages
Slovenian (sl)
Inventor
Richard Peregrine SmithKline Beecham Pharma BAX
Mike Gale SmithKline Beecham Pharma. RAMSEY
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508989.2A external-priority patent/GB9508989D0/en
Priority claimed from GBGB9523655.0A external-priority patent/GB9523655D0/en
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corporation filed Critical Smithkline Beecham Plc
Priority claimed from PCT/EP1996/001881 external-priority patent/WO1996034605A1/en
Publication of SI0825860T1 publication Critical patent/SI0825860T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9630321T 1995-05-03 1996-05-02 Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients SI0825860T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9508989.2A GB9508989D0 (en) 1995-05-03 1995-05-03 Pharmaceutical formulations
GBGB9523655.0A GB9523655D0 (en) 1995-11-18 1995-11-18 Method of treatment
PCT/EP1996/001881 WO1996034605A1 (en) 1995-05-03 1996-05-02 Composition comprising amoxycillin and clavulanic acid
EP96919679A EP0825860B1 (en) 1995-05-03 1996-05-02 Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients

Publications (1)

Publication Number Publication Date
SI0825860T1 true SI0825860T1 (en) 2002-02-28

Family

ID=27238000

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630321T SI0825860T1 (en) 1995-05-03 1996-05-02 Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients

Country Status (2)

Country Link
DE (1) DE29623843U1 (en)
SI (1) SI0825860T1 (en)

Also Published As

Publication number Publication date
DE29623843U1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
HK1009101A1 (en) Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients
MY115351A (en) Pharmaceutical formulations
HK1015701A1 (en) Use of paediatric pharmaceutical formulation comprising amoxycillin and clavulanate
AU4022697A (en) Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia
HK1041203A1 (en) Pharmaceutical composition comprising pioglitazone and glimepiride for use in treatment of diabetes
AU6897198A (en) Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
AU6042696A (en) Drug delivery catheters and methods of use
AU3777597A (en) Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
IL130784A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same
AU8015398A (en) Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU7681091A (en) Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
AU3733295A (en) Treatment of obstructive airway disease by administering thymosin beta 4, or coadministration of thymosin beta 4 and dnase i
PL327168A1 (en) Pharmaceutical compositions suitable for use in treatment of diseases associated with venal lesions and/or inflammatore oedema and novel compounds used in such compositions
SI0825860T1 (en) Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients
NZ299257A (en) Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase
AU4819993A (en) Drug for treatment and prophylaxis of bone and joint diseases
IL82767A0 (en) Pharmaceutical formulation comprising a cephem and a penem derivative for the treatment of bacterial infections
HUP9802450A3 (en) Use of prostane derivatives and the combination thereof for preparing pharmaceutical compositions for use in treatment of bacterial infections
AU8195091A (en) Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease
AU1968399A (en) Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections
AU657249B3 (en) Methods of diagnosis in oral medicine and dental therapy
AU4023889A (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
AU6731594A (en) Medical treatment and preparation
LV5179A3 (en) Preparation of "ethoxidine" for prophylaxis and treatment of almost all diseases of the lungs and bowels